 What to know New research shows retatrutide, a potent GLP-1 drug, may reduce knee pain and aid weight loss in people with obesity and knee osteoarthritis. The studies, funded by retatrutide maker Eli Lilly, found significant pain relief and weight loss among participants. However, questions remain about whether the drug's effects on knee pain are independent of weight loss. Eli Lilly likely plans to seek FDA approval for retatrutide next year. Summary is AI-generated, newsroom-reviewed. |
Have a question? Ask the Post AI to learn more 
